Ellenbecker Investment Group Sells 249 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Ellenbecker Investment Group trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 5.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,053 shares of the healthcare conglomerate’s stock after selling 249 shares during the period. UnitedHealth Group accounts for 0.4% of Ellenbecker Investment Group’s portfolio, making the stock its 24th largest holding. Ellenbecker Investment Group’s holdings in UnitedHealth Group were worth $2,370,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of UNH. Kathleen S. Wright Associates Inc. purchased a new position in UnitedHealth Group during the third quarter valued at $27,000. Global Wealth Strategies & Associates grew its stake in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares in the last quarter. Macroview Investment Management LLC grew its stake in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 47 shares in the last quarter. West Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth $32,000. Finally, Delos Wealth Advisors LLC grew its stake in shares of UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on UNH. TD Cowen lifted their price target on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Cantor Fitzgerald boosted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a report on Wednesday. KeyCorp assumed coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 target price on the stock. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Wednesday. Finally, HSBC downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $615.16.

View Our Latest Stock Analysis on UNH

UnitedHealth Group Trading Up 0.2 %

Shares of UNH opened at $566.94 on Friday. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63. The firm has a 50-day moving average price of $584.20 and a 200 day moving average price of $533.07. The firm has a market capitalization of $523.52 billion, a P/E ratio of 37.53, a P/E/G ratio of 1.69 and a beta of 0.58.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.56 earnings per share. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.68 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.48%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 55.70%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.